Global Transaminase Test Market Size & Outlook, 2025-2033
Global transaminase test market, 2021-2033 (US$M)
Related Markets
Global transaminase test market highlights
- The global transaminase test market generated a revenue of USD 4,101.8 million in 2024 and is expected to reach USD 7,805.3 million by 2033.
- The market is expected to grow at a CAGR (2025 - 2033) of 7.5% by 2033.
- In terms of segment, automated analyzers accounted for a revenue of USD 2,291.4 million in 2024.
- Paper-Based / Lab-on-a-Chip Platforms is the most lucrative technology segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2024.
- Country-wise, China is expected to register the highest CAGR from 2025 to 2033.
Global data book summary
| Market revenue in 2024 | USD 4,101.8 million |
| Market revenue in 2033 | USD 7,805.3 million |
| Growth rate | 7.5% (CAGR from 2025 to 2033) |
| Largest segment | Automated analyzers |
| Fastest growing segment | Paper-Based / Lab-on-a-Chip Platforms |
| Historical data covered | 2021 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Automated Analyzers, Semi-Automated & Manual Systems, Point-of-Care (POC) Devices, Paper-Based / Lab-on-a-Chip Platforms |
Other key industry trends
- In terms of revenue, the North America accounted for 33.6% of the global transaminase test market in 2024.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2033.
- By country, China is the fastest growing regional market and is projected to reach USD 435.8 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Transaminase Test Market Scope
Transaminase Test Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Alpha Laboratories | View profile | 11-50 | Eastleigh, Hampshire, United Kingdom, Europe | https://www.alphalabs.co.uk |
| Randox | View profile | 1001-5000 | Crumlin, Antrim, United Kingdom, Europe | http://www.randox.com |
| Bruker Corp | View profile | 9707 | 40 Manning Road, Billerica, MA, United States, 01821 | https://www.bruker.com |
| Labcorp Holdings Inc | View profile | 67000 | 358 South Main Street, Burlington, NC, United States, 27215 | https://www.labcorp.com |
| Bio-Rad Laboratories Inc | View profile | 8030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | https://www.bio-rad.com |
| Horiba Ltd | View profile | 8665 | 2, Miyanohigashi-cho, Kisshoin, Minami-ku, Kyoto, Japan, 601-8510 | http://www.horiba.co.jp |
| Danaher Corp | View profile | 63000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | https://www.danaher.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Siemens Healthineers AG ADR | View profile | 71400 | Siemensstr. 3, Forchheim, BY, Germany, 91301 | https://www.siemens-healthineers.com |
| BioMerieux SA | View profile | 13982 | Marcy l’Etoile, Lyon, France, 69280 | http://www.biomerieux.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
| Roche Holding AG ADR | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
Global transaminase test market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to transaminase test market will help companies and investors design strategic landscapes.
Automated analyzers was the largest segment with a revenue share of 55.86% in 2024. Horizon Databook has segmented the Global transaminase test market based on automated analyzers, semi-automated & manual systems, point-of-care (poc) devices, paper-based / lab-on-a-chip platforms covering the revenue growth of each sub-segment from 2021 to 2033.
- Global Transaminase Test Technology Outlook (Revenue, USD Million, 2021-2033)
- Automated Analyzers
- Semi-Automated & Manual Systems
- Point-of-Care (POC) Devices
- Paper-Based / Lab-on-a-Chip Platforms
- Others
- Global Transaminase Test Test Type Outlook (Revenue, USD Million, 2021-2033)
- ALT Test
- AST Test
- Combined Transaminase Panels
- Others
- Global Transaminase Test Application Outlook (Revenue, USD Million, 2021-2033)
- Liver Disease Diagnosis & Monitoring
- Hepatitis Screening
- Drug-Induced Liver Injury (DILI) Monitoring
- Others
- Global Transaminase Test End Use Outlook (Revenue, USD Million, 2021-2033)
- Hospitals & Clinics
- Diagnostic Laboratories (centralized testing)
- Research Institutes
- Home Testing
- Others
Reasons to subscribe to Global transaminase test market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global transaminase test market databook
-
Our clientele includes a mix of transaminase test market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global transaminase test market , including forecasts for subscribers. This global databook contains high-level insights into Global transaminase test market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Global transaminase test market size, by regions, 2021-2033 (US$M)
Top 10 countries: Transaminase test market size, 2024 (US$M)
Global transaminase test market share, by technology, 2024 & 2033 (%, US$M)
Transaminase test market: Opportunity assessment by country
Global transaminase test market, by region, 2024 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
